[Ovarian serous tumors of limited malignancy and invasive peritoneal implants. Review of the literature].
The prognosis for patients with ovarian serous borderline tumors is generally considered to be excellent. It is worse for women with an advanced stage, especially when invasive peritoneal implants are present. There is no general agreement regarding standard treatment in such cases. To clarify the significance of this invasive peritoneal proliferation and to devise a rational treatment approach, we review the available series. From this review of literature, it appears necessary to emphasize the importance of an initial adequate peritoneal staging of all ovarian tumors. After a complete removal of the lesions, the question of adjuvant therapy must be discussed.
Fondrinier
E
E
Centre Paul Papin, Angers, France.
Seince
N
N
Verriele
V
V
Lorimier
G
G
Gamelin
E
E
D018293:Cystadenoma, Serous / Q000175:diagnosis / Q000401:mortality / Q000556:secondary / Q000628:therapy; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000473:pathology*; D010534:Peritoneal Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000556:secondary / Q000628:therapy; D011379:Prognosis; D012307:Risk Factors; D016019:Survival Analysis; D016896:Treatment Outcome